CYP19 gene: a genetic modifier of polycystic ovary syndrome phenotype

Fertility and Sterility

Volumn 94, Issue 1, 2010, Pages 250-254

  Xita, Nectaria ^a   Lazaros, Leandros ^a   Georgiou, Ioannis ^a   Tsatsoulis, Agathocles ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

aromatase; CYP19; hyperandrogenemia; PCOS; polymorphism

Indexed keywords

ADENINE; ANDROGEN; AROMATASE; DNA; ESTROGEN; FOLLITROPIN; GLUCOSE; INSULIN; LUTEINIZING HORMONE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TYROSINE;

ADULT; ALLELE; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CONTROLLED STUDY; DIET RESTRICTION; DNA MODIFICATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HORMONE DETERMINATION; HUMAN; HYPERANDROGENISM; MAJOR CLINICAL STUDY; NUCLEOTIDE REPEAT; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; ALLELES; AROMATASE; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC MARKERS; HUMANS; PHENOTYPE; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, GENETIC; YOUNG ADULT;

EID: 77952541264     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.01.147     Document Type: Article

References (21)

1. Legro R.S., Driscoll D., Strauss III J.F., Fox J., and Dunaif A. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci U S A 95 (1998) 14956-14960
2. Abbott D.H., Dumesic D.A., and Franks S. Developmental origin of polycystic ovary syndrome-a hypothesis. J Endocrinol 174 (2002) 1-5
3. Xita N., and Tsatsoulis A. Fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies. J Clin Endocrinol Metab 91 (2006) 1660-1666
4. Xita N., Tsatsoulis A., Chatzikyriakidou A., and Georgiou I. Association of the (TAAAA)n repeat polymorphism in the sex hormone-binding globulin (SHBG) gene with polycystic ovary syndrome and relation to SHBG levels. J Clin Endocrinol Metab 88 (2003) 5976-5980
5. Gharani N., Waterworth D.M., Batty S., White D., Gilling-Smith C., Conway G.S., et al. Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism. Hum Mol Genet 6 (1997) 397-402
6. Urbanek M., Legro R.S., Driscoll D.A., Azziz R., Ehrmann D.A., Norman R.J., et al. Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc Natl Acad Sci U S A 96 (1999) 8573-8578
7. Soderlund D., Canto P., Carranza-Lira S., and Mendez J.P. No evidence of mutations in the P450 aromatase gene in patients with polycystic ovary syndrome. Hum Reprod 20 (2005) 965-969
8. Petry C.J., Ong K.K., Michelmore K.F., Artigas S., Wingate D.L., Balen A.H., et al. Association of aromatase (CYP19) gene variation with features of hyperandrogenism in two populations of young women. Hum Reprod 20 (2005) 1837-1843
9. Baghaei F., Rosmond R., Westberg L., Hellstrand M., Eriksson E., Holm G., et al. The CYP19 gene and associations with androgens and abdominal obesity in premenopausal women. Obes Res 11 (2003) 578-585
10. Zawadzki J.K., and Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A., Givens J.R., Haseltine F., and Merriam G.R. (Eds). Polycystic ovary syndrome (1992), Blackwell, Boston 377-384
11. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81 (2004) 19-25
12. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19 (2004) 41-47
13. Taieb J., Mathian B., Millot F., Patricot M.C., Mathieu E., Queyrel N., et al. Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. Clin Chem 49 (2003) 1381-1395
14. Gennari L., Masi L., Merlotti D., Picariello L., Falchetti A., Tanini A., et al. A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism. J Clin Endocrinol Metab 89 (2004) 2803-2810
15. Kristensen V.N., Harada N., Yoshimura N., Haraldsen E., Lonning P.E., Erikstein B., et al. Genetic variants of CYP19 (aromatase) and breast cancer risk. Oncogene 19 (2000) 1329-1333
16. Gabrilove J.L. The pathogenesis of the polycystic ovary syndrome: a hypothesis. Endocr Pract 8 (2002) 127-132
17. Ito Y., Fisher C.R., Conte F.A., Grumbach M.M., and Simpson E.R. Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries. Proc Natl Acad Sci U S A 90 (1993) 11673-11677
18. Belgorosky A., Pepe C., Marino R., Guercio G., Saraco N., Vaiani E., et al. Hypothalamic-pituitary-ovarian axis during infancy, early and late prepuberty in an aromatase-deficient girl who is a compound heterozygote for two new point mutations of the CYP19 gene. J Clin Endocrinol Metab 88 (2003) 5127-5131
19. Shetty G., Krishnamurthy H., Krishnamurthy H.N., Bhatnagar A.S., and Moudgal R.N. Effect of estrogen deprivation on the reproductive physiology of male and female primates. J Steroid Biochem Mol Biol 61 (1997) 157-166
20. Britt K.L., and Findlay J.K. Estrogen actions in the ovary revisited. J Endocrinol 175 (2002) 269-276
21. Takayama K., Fukaya T., Sasano H., Funayama Y., Suzuki T., Takaya R., et al. Immunohistochemical study of steroidogenesis and cell proliferation in polycystic ovarian syndrome. Hum Reprod 11 (1996) 1387-1392